56 datasets found

Filter Results

  • PRISMA Questionnaire data

    The extensive questionnaire covers a number of potential breast cancer risk predictors such as demographics, personal characteristics, reproductive characteristics, medication,...

  • PRIDE Study questionnaire data

    In this ongoing prospective cohort study, women complete web-based questionnaires at three time points in pregnancy (at enrollment [median gestational age 10 weeks], gestational...

  • ReLife study general questionnaire

    Patients with localized stage I-III renal cell cancer (n=365) completed paper-and-pencil or web-based questionnaires at 3 months (n=368), 12 months (n=317), and 24 months...

  • ReLife study clinical data

    Data on tumour characteristics, treatment, complications, recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer...

  • UroLife study general questionnaire

    Patients with non-muscle invasive bladder cancer (n=1512) completed paper-and-pencil or web-based questionnaires at 6 weeks (referring to pre-diagnosis lifestyle; n=1486) and 3...

  • PRIDE Study paternal questionnaire data

    Questionnaire data focusing on paternal exposures the 3 months before conception. Completed by the biological father, <50% participation rate.

  • POM clinical data

    Clinical data of the Personalized Parkinson Project, including motor scores, cognitive and neuropsychiatric assessments, autonomic symptoms, sleep and quality of life.

  • ReLife study food frequency questionnaire

    A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery.

  • PRIDE Study obstetric records

    Selected clinical data from obstetric records covering the pregnancy period and puerperium. Necessitates additional consent, provided by ~70% of participants

  • ReLife study blood samples

    Serum and EDTA plasma samples were collected at 3 (n=335), 12 (n=266) and 24 months (n=237) after surgery. EDTA plasma samples have been analysed for CRP, IL-6, adiponectin, and...

  • ReLife study quality of life questionnaire

    The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery.

  • UroLife study quality of life questionnaire

    The EORTC QLQ-C30 and EORTC QLQ-NMIBC24 was completed at 6 weeks (n=1451) and 3 (n=1334), 15 (n=1159) and 51 months (n=588) after diagnosis.

  • UroLife study blood samples

    EDTA and heparin plasma samples were collected at 3 (n=1280) and 15 months (n=1122) after diagnosis. Heparin plasma samples have been analysed for carotenoids at 3 and 15 months...

  • EATRIS-Plus multi-omics data of a human reference cohort

    In this reference study, blood samples of 127 healthy individuals were analyzed with a wide range of -omics technologies. The profiling data set is publicly available.

  • PRIDE Study medication diaries

    6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants...

  • POM biomaterials

    Biomaterials of the Personalized Parkinson Project, including blood, CSF and stool samples.

  • UroLife study genome-wide germline SNP data

    Isolated DNA and genome-wide germline SNP data is available for 1213 patients.

  • ReLife study food frequency questionnaire

    A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery.

  • PRIDE Study medication diaries

    6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants...

  • ReLife study body composition data

    CT-based assessment of body composition is available for n=349 patients.